XHKG2120
Market cap113mUSD
Dec 24, Last price
12.50HKD
1D
1.13%
1Q
-3.85%
Jan 2017
-63.24%
IPO
-74.54%
Name
Wenzhou Kangning Hospital Co Ltd
Chart & Performance
Profile
Wenzhou Kangning Hospital Co., Ltd. operates and manages a network of healthcare facilities in the People's Republic of China. It primarily focuses on providing psychiatric specialty care. The company also provides property leasing and sale services; and software and information technology services, as well as hospital management, forensic authentication, and medical services. It is also engaged in pharmaceutical retail. The company was formerly known as Wenzhou City Kangning Psychiatric Rehabilitation Hospital and changed its name to Wenzhou Kangning Hospital Co., Ltd. in October 2014. Wenzhou Kangning Hospital Co., Ltd. was founded in 1996 and is headquartered in Wenzhou, the People's Republic of China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 1,596,266 7.50% | 1,484,903 14.45% | 1,297,430 25.81% | |||||||
Cost of revenue | 1,286,152 | 1,239,297 | 1,048,142 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 310,114 | 245,606 | 249,288 | |||||||
NOPBT Margin | 19.43% | 16.54% | 19.21% | |||||||
Operating Taxes | 12,250 | 26,574 | 54,831 | |||||||
Tax Rate | 3.95% | 10.82% | 21.99% | |||||||
NOPAT | 297,864 | 219,033 | 194,457 | |||||||
Net income | 85,948 | 44,036 -21.04% | ||||||||
Dividends | (32,397) | |||||||||
Dividend yield | 3.22% | |||||||||
Proceeds from repurchase of equity | (21,278) | |||||||||
BB yield | 2.11% | |||||||||
Debt | ||||||||||
Debt current | 335,666 | 252,016 | 302,291 | |||||||
Long-term debt | 912,842 | 759,434 | 774,458 | |||||||
Deferred revenue | 8,734 | 9,038 | 9,342 | |||||||
Other long-term liabilities | 108,657 | 42,405 | 1 | |||||||
Net debt | 618,125 | 533,692 | 692,354 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 265,033 | 227,221 | 193,896 | |||||||
CAPEX | (179,732) | |||||||||
Cash from investing activities | (215,017) | |||||||||
Cash from financing activities | 96,107 | 116,178 | 33,833 | |||||||
FCF | 265,928 | 290,308 | (2,247) | |||||||
Balance | ||||||||||
Cash | 426,212 | 281,736 | 198,735 | |||||||
Long term investments | 204,171 | 196,022 | 185,660 | |||||||
Excess cash | 550,570 | 403,513 | 319,523 | |||||||
Stockholders' equity | 529,698 | 432,425 | 394,523 | |||||||
Invested Capital | 2,005,218 | 1,754,789 | 1,745,646 | |||||||
ROIC | 15.84% | 12.51% | 11.91% | |||||||
ROCE | 12.01% | 11.17% | 11.84% | |||||||
EV | ||||||||||
Common stock shares outstanding | 74,600 | 74,600 | 74,600 | |||||||
Price | 13.50 | 21.00 -24.60% | ||||||||
Market cap | 1,007,104 | 1,566,606 -23.91% | ||||||||
EV | 1,768,370 | 2,330,976 | ||||||||
EBITDA | 423,664 | 359,817 | 353,873 | |||||||
EV/EBITDA | 4.17 | 6.59 | ||||||||
Interest | 39,936 | 45,150 | 36,268 | |||||||
Interest/NOPBT | 12.88% | 18.38% | 14.55% |